Naratriptan Tablet, Film Coated
Product Images NDC 69452-340
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Naratriptan (NDC 69452-340). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Naratriptan Tablets Figure 2)
Figure 2 (Naratriptan Tablets Figure 3)
This appears to be a graph displaying the estimated probability of remedication or rescue over time in hours from the initial dose. The graph shows a probability of 100% at the beginning and a time scale ranging from 0 to 20 hours with markers at 10 and 15 hours. It is not possible to determine what type of medication or rescue is being referred to without further context.*
1 mg Carton (Naratriptan Tablets Figure 4)
2.5 mg Carton (Naratriptan Tablets Figure 5)
This is a description of Naratriptan Tablets, USP, a medication used for migraines. Each coated tablet contains 25g of naratriptan. The dosage information is available with the prescribing information. The tablets should not be used if the blister pack is tampered with or damaged. The package is child-resistant. Opening the blister pack requires tearing it along the perforations and pushing the tablet through the hole. The tablets are distributed by Bionpharma Inc. and should be stored in a controlled room temperature range of 20° to 25°C. The product is made in India and comes in a pack of 9 unit-of-use tablets. The product should only be dispensed by a pharmacist with the patient information leaflet.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.